Feldman AS, Efstathiou JA, Lee RJ, Dahl DM, Michaelson MD, Zietman AL. Cancer of the bladder, ureter, and renal pelvis. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 65:896-916.
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs - Part B: Prostate and Bladder Tumours. (2016, July). European Urology. 70(1):106-119. Extrait de: https://www.europeanurology.com/article/S0302-2838(16)00205-0/fulltext.
Jarrard DF. (2016, September 18). Medscape Reference: Urothelial Tumors of the Renal Pelvis and Ureters. Extrait de: https://emedicine.medscape.com/article/452449-overview.
Leow JJ, Chong KT, Chang SL, Bellmunt J. Upper tract urothelial carcinoma: a different disease entity in terms of management. (2017). ESMO Open. 1:e000126. Extrait de: https://esmoopen.bmj.com/content/1/6/e000126.
Mark JR. Renal pelvic and ureteral cancers. Porter RS (ed.). (2017, October). Merck Manual Professional Edition. Kenilworth, NJ: Merck Sharp & Dohme Corp. Accessed November 8, 2018. Extrait de: https://www.merckmanuals.com/en-ca/professional/genitourinary-disorders/genitourinary-cancer/renal-pelvic-and-ureteral-cancers.
National Cancer Institute. (2018, February 7). Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®) Health Professional Version. Extrait de: https://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq.×